AZ sues nine generics makers over Crestor copies; Takeda settles six Actos patent fights;

   @FiercePharma: The pharma trifecta: Generics, new markets, and personalization. Report | Follow @FiercePharma

> AstraZeneca accused nine rivals--including Teva Pharmaceutical Industries--of patent infringement over plans to market copycat versions of the cholesterol-control drug Crestor. Report

> Takeda says it has wrapped up settlements in six of eight patent fights concerning possible generic versions of its diabetes blockbusters Actos and Actoplus Met. Report

> French cosmetics giant L'Oreal said it was in no hurry to sell its 8.6 percent stake in pharmaceuticals group Sanofi-Aventis, which it described as a financial investment. Report

> European parliamentarians voted overwhelmingly yesterday to include Internet drug sales in European Union legislation aimed at preventing counterfeit medicines from entering the supply chain. Report

> Laws requiring "chemo parity," equal treatment of cancer drugs whether they are oral meds or IV treatments, have been adopted by a handful of states, but problems remain. Report

> Obesity could affect how children metabolize medication, according to a study presented this week. Report

Biotech News

 @FierceBiotech: Consultant: Smart biotech money betting on innovation. Story | Follow @FierceBiotech    

 @JohnCFierce: E&Y tells FierceBiotech that developers need to make a case early on that their drug a.) significantly cheaper or b.) more effective than available meds.| Follow @JohnCFierce

> Pfizer developing "bio-betters," seeking rare blood disorder drugs. Report

> Lycera banks $11 million tranche for immunomodulator programs. Story

> BioCryst shares surge on positive PhIIa gout data. Article

> E&Y: A resilient biotech industry registers its first profitable year. Item

Medical Devices 

> Guidant's $296M 'landmark' plea rejected by judge. News

> FDA issues warning on 14 faulty debrillator models. Story

> Covidien recalls tracheostomy tubes after deaths. Report

> Boston Sci CTO Colen to retire. Article

> HeartWare begins partial recall of controller. Report

> Proteus raises $25M, gets Raisin 510(k). Story

DrugDelivery

> Nanoparticle vax cures Type 1 diabetes in mice. Article

> Anti-Notch1 mAb demonstrates potent inhibitory activity. Story

> FDA approves first oral formulation of Miconazole. Report

> Nanoscale could delivery medication into cell wall. Item

And Finally... A new study links progression of a lethal type of brain tumor with reduced expression of more than 600 immune system genes. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.